The relationship between anxiety and levels of Alzheimer's disease plasma biomarkers

被引：0
|
作者：
Bernard, Mark A. [1 ,2 ]
Boutajangout, Allal [1 ,2 ]
Debure, Ludovic [1 ,2 ]
Ahmed, Wajiha [1 ,2 ]
Briggs, Anthony Q. [1 ,2 ]
Boza-Calvo, Carolina [2 ,3 ,4 ]
Vedvyas, Alok [1 ,2 ]
Marsh, Karyn [1 ,2 ]
Bubu, Omonigho M. [1 ,2 ,5 ]
Osorio, Ricardo S. [2 ,5 ]
Wisniewski, Thomas [1 ,2 ,6 ]
Masurkar, Arjun, V [1 ,2 ,6 ]
机构：
[1] NYU, Ctr Cognit Neurol, Dept Neurol, Grossman Sch Med, New York, NY 10016 USA
[2] NYU, Alzheimers Dis Res Ctr, Grossman Sch Med, New York, NY 10012 USA
[3] Univ Costa Rica, Ctr Invest Hematol & Trastornos Afines CIHATA, San Jose, Costa Rica
[4] Univ Costa Rica, Escuela Med, San Jose, Costa Rica
[5] NYU, Grossman Sch Med, Dept Psychiat, New York, NY USA
[6] NYU, Neurosci Inst, Grossman Sch Med, New York, NY USA
来源：
JOURNAL OF ALZHEIMERS DISEASE | 2024年 / 102卷 / 04期
关键词：
Alzheimer's disease; anxiety; biomarkers; dementia; plasma; MILD BEHAVIORAL IMPAIRMENT; NEUROPSYCHIATRIC SYMPTOMS; COGNITIVE IMPAIRMENT; DEMENTIA; RISK; ASSOCIATION; COHORT;
D O I：
10.1177/13872877241295324
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Anxiety is highly prevalent in Alzheimer's disease (AD), correlating with cerebrospinal fluid/positron emission tomography biomarkers and disease progression. Relationships to plasma biomarkers are unclear. Herein, we compare levels of plasma biomarkers in research participants with and without anxiety at cognitively normal, mild cognitive impairment, and AD dementia stages. We observed significantly higher plasma tau/amyloid-beta(42) ratio in AD participants with anxiety versus those without, but did not observe differences at other stages or plasma biomarkers. No such relationships were evident with depression. These results support a unique pathophysiological relationship between anxiety and AD that can be reflected in plasma biomarkers, suggestive of heightened neurodegeneration.
引用
收藏
页码：987 / 993
页数：7
相关论文
共 50 条
  • [1] The Relationship Between Anxiety and Alzheimer's Disease
    Mendez, Mario E.
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2021, 5 (01) : 171 - 177
  • [2] The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease
    Liu, Kathy Y.
    Costello, Harry
    Reeves, Suzanne
    Howard, Robert
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (03) : 1119 - 1127
  • [3] Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
    Toniolo, Sofia
    Zhao, Sijia
    Scholcz, Anna
    Amein, Benazir
    Ganse-Dumrath, Akke
    Heslegrave, Amanda J.
    Thompson, Sian
    Manohar, Sanjay
    Zetterberg, Henrik
    Husain, Masud
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2024, 16 (02)
  • [4] Plasma biomarkers of Alzheimer's disease
    Kawarabayashi, Takeshi
    Shoji, Mikio
    CURRENT OPINION IN PSYCHIATRY, 2008, 21 (03) : 260 - 267
  • [5] Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging
    Abner, Erin L.
    Jicha, Gregory A.
    Shaw, Leslie M.
    Trojanowski, John Q.
    Goetzl, Edward J.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (05): : 399 - 403
  • [6] Plasma miRNAs across the Alzheimer's disease continuum: Relationship to central biomarkers
    Liu, Shiwei
    Park, Tamina
    Kruger, Dennis M.
    Pena-Centeno, Tonatiuh
    Burkhardt, Susanne
    Schutz, Anna-Lena
    Huang, Yen-Ning
    Rosewood, Thea
    Chaudhuri, Soumilee
    Cho, MinYoung
    Risacher, Shannon L.
    Wan, Yang
    Shaw, Leslie M.
    Sananbenesi, Farahnaz
    Brodsky, Alexander S.
    Lin, Honghuang
    Krunic, Andre
    Blusztajn, Jan Krzysztof
    Saykin, Andrew J.
    Delalle, Ivana
    Fischer, Andre
    Nho, Kwangsik
    ALZHEIMERS & DEMENTIA, 2024, 20 (11) : 7698 - 7714
  • [7] Inflammatory biomarkers in Alzheimer's disease plasma
    Morgan, Angharad R.
    Touchard, Samuel
    Leckey, Claire
    O'Hagan, Caroline
    Nevado-Holgado, Alejo J.
    Barkhof, Frederik
    Bertram, Lars
    Blin, Olivier
    Bos, Isabelle
    Dobricic, Valerija
    Engelborghs, Sebastiaan
    Frisoni, Giovanni
    Froelich, Lutz
    Gabel, Silvey
    Johannsen, Peter
    Kettunen, Petronella
    Koszewska, Iwona
    Legido-Quigley, Cristina
    Lleo, Alberto
    Martinez-Lage, Pablo
    Mecocci, Patrizia
    Meersmans, Karen
    Luis Molinuevo, Jose
    Peyratout, Gwendoline
    Popp, Julius
    Richardson, Jill
    Sala, Isabel
    Scheltens, Philip
    Streffer, Johannes
    Soininen, Hikka
    Tainta-Cuezva, Mikel
    Teunissen, Charlotte
    Tsolaki, Magda
    Vandenberghe, Rik
    Visser, Pieter Jelle
    Vos, Stephanie
    Wahlund, Lars-Olof
    Wallin, Anders
    Westwood, Sarah
    Zetterberg, Henrik
    Lovestone, Simon
    Morgan, B. Paul
    Bullmore, Edward T.
    Bhatti, Junaid
    Chamberlain, Samuel J.
    Correia, Marta M.
    Crofts, Anna L.
    Dickinson, Amber
    Foster, Andrew C.
    Kitzbichler, Manfred G.
    ALZHEIMERS & DEMENTIA, 2019, 15 (06) : 776 - 787
  • [8] Relationship between a novel learning slope metric and Alzheimer's disease biomarkers
    Hammers, Dustin B.
    Suhrie, Kayla
    Dixon, Ava
    Gradwohl, Brian D.
    Archibald, Zane G.
    King, Jace B.
    Spencer, Robert J.
    Duff, Kevin
    Hoffman, John M.
    AGING NEUROPSYCHOLOGY AND COGNITION, 2022, 29 (05) : 799 - 819
  • [9] Relationship between cerebral amyloid angiopathy and CSF biomarkers in Alzheimer's disease
    Kanemaru, K.
    Sengoku, R.
    Nishina, Y.
    Murayama, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 667 - 667
  • [10] The Relationship between Serum Endocan Levels and Depression in Alzheimer's Disease
    Yoon, Kyung Hee
    Kim, So Yeon
    Moon, Yoo Sun
    Roh, Daeyoung
    Lee, Sang Kyu
    Kim, Do Hoon
    DISEASE MARKERS, 2016, 2016
12345